Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the host

Eukaryotic Cell

Volumn 9, Issue 8, 2010, Pages 1193-1202

  O'Meara, Teresa R ^a   Hay, Christie ^a   Price, Michael S ^a   Giles, Steve ^a   Alspaugh, J Andrew ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FUNGAL PROTEIN; GCN5 PROTEIN, S CEREVISIAE; HISTONE ACETYLTRANSFERASE; SACCHAROMYCES CEREVISIAE PROTEIN;

ADAPTATION; ARTICLE; CELL NUCLEUS; CRYPTOCOCCUS NEOFORMANS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MUTATION; PATHOGENICITY; PHYSIOLOGICAL STRESS; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; TEMPERATURE; VIRULENCE; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS;

ADAPTATION, PHYSIOLOGICAL; CELL NUCLEUS; CRYPTOCOCCUS NEOFORMANS; ENZYME INHIBITORS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENETIC COMPLEMENTATION TEST; HISTONE ACETYLTRANSFERASES; HOST-PATHOGEN INTERACTIONS; HUMANS; MUTATION; PROTEIN TRANSPORT; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; STRESS, PHYSIOLOGICAL; TEMPERATURE; VIRULENCE;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 77956791063     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00098-10     Document Type: Article

References (69)

1. Alspaugh, J., J. R. Perfect, and J. Heitman. 1998. Signal transduction pathways regulating differentiation and pathogenicity of Cryptococcus neoformans. Fungal Genet. Biol. 25:1-14.
2. Bahn, Y. 2008. Master and commander in fungal pathogens: the two-component system and the HOG signaling pathway. Eukaryot. Cell 7:2017-2036.
3. Bahn, Y., K. Kojima, G. Cox, and J. Heitman. 2005. Specialization of the HOG pathway and its impact on differentiation and virulence of Cryptococcus neoformans. Mol. Biol. Cell 16:2285-2300.
4. Bahn, Y.-S., K. Kojima, G. M. Cox, and J. Heitman. 2006. A unique fungal two-component system regulates stress responses, drug sensitivity, sexual development, and virulence of Cryptococcus neoformans. Mol. Biol. Cell 17:3122-3135.
5. Baker, S. P., and P. A. Grant. 2007. The SAGA continues: expanding the cellular role of a transcriptional co-activator complex. Oncogene 26:5329-5340.
6. Balasubramanyam, K., M. Altaf, R. A. Varier, V. Swaminathan, A. Ravindran, P. P. Sadhale, and T. K. Kundu. 2004. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 279: 33716-33726.
7. Ballou, E. R., C. B. Nichols, K. J. Miglia, L. Kozubowski, and J. A. Alspaugh. 2010. Two CDC42 paralogues modulate Cryptococcus neoformans thermotolerance and morphogenesis under host physiological conditions. Mol. Microbiol. 75:763-780.
8. Bhatti, M. M., and W. J. Sullivan, Jr. 2005. Histone acetylase GCN5 enters the nucleus via importin-alpha in protozoan parasite Toxoplasma gondii. J. Biol. Chem. 280:5902-5908.
9. Brown, C. E., T. Lechner, L. Howe, and J. L. Workman. 2000. The many HATs of transcription coactivators. Trends Biochem. Sci. 25:15-19.
10. Brown, S. M., L. T. Campbell, and J. K. Lodge. 2007. Cryptococcus neoformans, a fungus under stress. Curr. Opin. Microbiol. 10:320-325.
11. Carrozza, M. J., R. T. Utley, J. L. Workman, and J. Côté. 2003. The diverse functions of histone acetyltransferase complexes. Trends Genet. 19:321-329.
12. Casadevall, A., W. Cleare, M. Feldmesser, A. Glatman-Freedman, D. L. Goldman, T. R. Kozel, N. Lendvai, J. Mukherjee, L.-A. Pirofski, J. Rivera, A. L. Rosas, M. D. Scharff, P. Valadon, K. Westin, and Z. Zhong. 1998. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob. Agents Chemother. 42:1437-1446.
13. Chang, Y. C., and K. J. Kwon-Chung. 1994. Complementation of a capsuledeficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14:4912-4919.
14. Chang, Z. L., D. Netski, P. Thorkildson, and T. R. Kozel. 2006. Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages. Infect. Immun. 74:144-151.
15. Cox, G. M., J. Mukherjee, G. T. Cole, A. Casadevall, and J. R. Perfect. 2000. Urease as a virulence factor in experimental cryptococcosis. Infect. Immun. 68:443-448.
16. Cramer, K. L., Q. D. Gerrald, C. B. Nichols, M. S. Price, and J. A. Alspaugh. 2006. Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans. Eukaryot. Cell 5:1147-1156.
17. Cui, L., J. Miao, T. Furuya, Q. Fan, X. Li, P. K. Rathod, X.-Z. Su, and L. Cui. 2008. Histone acetyltransferase inhibitor anacardic acid causes changes in global gene expression during in vitro Plasmodium falciparum development. Eukaryot. Cell 7:1200-1210.
18. D'Souza, C. A., J. A. Alspaugh, C. Yue, T. Harashima, G. M. Cox, J. R. Perfect, and J. Heitman. 2001. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol. Cell. Biol. 21:3179-3191.
19. Eberharter, A., D. E. Sterner, D. Schieltz, A. Hassan, J. R. Yates III, S. L. Berger, and J. L. Workman. 1999. The ADA complex is a distinct histone acetyltransferase complex in Saccharomyces cerevisiae. Mol. Cell. Biol. 19: 6621-6631.
20. Fan, Q., L. An, and L. Cui. 2004. Plasmodium falciparum histone acetyltransferase, a yeast GCN5 homologue involved in chromatin remodeling. Eukaryot. Cell 3:264-276.
21. Fan, W., P. R. Kraus, M.-J. Boily, and J. Heitman. 2005. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot. Cell 4:1420-1433.
22. Fox, D. S., M. C. Cruz, R. A. L. Sia, H. Ke, G. M. Cox, M. E. Cardenas, and J. Heitman. 2001. Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12 and FK506 in Cryptococcus neoformans. Mol. Microbiol. 39:835-849.
23. Fraser, J. A., R. L. Subaran, C. B. Nichols, and J. Heitman. 2003. Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada. Eukaryot. Cell 2:1036-1045.
24. Geunes-Boyer, S., T. N. Oliver, G. Janbon, J. K. Lodge, J. Heitman, J. R. Perfect, and J. R. Wright. 2009. Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect. Immun. 77:2783-2794.
25. Gilbert, N. M., M. J. Donlin, K. J. Gerik, C. A. Specht, J. T. Djordjevic, C. F. Wilson, T. C. Sorrell, and J. K. Lodge. 2010. KRE genes are required for B-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformans. Mol. Microbiol. 76:517-534.
26. Giles, S. S., I. Batinic-Haberle, J. R. Perfect, and G. M. Cox. 2005. Cryptococcus neoformans mitochondrial superoxide dismutase: an essential link between antioxidant function and high-temperature growth. Eukaryot. Cell 4:46-54.
27. Giles, S. S., J. E. Stajich, C. Nichols, Q. D. Gerrald, J. A. Alspaugh, F. Dietrich, and J. R. Perfect. 2006. The Cryptococcus neoformans catalase gene family and its role in antioxidant defense. Eukaryot. Cell 5:1447-1459.
28. Goins, C. L., K. J. Gerik, and J. K. Lodge. 2006. Improvements to gene deletion in the fungal pathogen Cryptococcus neoformans: absence of Ku proteins increases homologous recombination, and co-transformation of independent DNA molecules allows rapid complementation of deletion phenotypes. Fungal Genet. Biol. 43:531-544.
29. Govind, C. K., S. Yoon, H. Qiu, S. Govind, and A. G. Hinnebusch. 2005. Simultaneous recruitment of coactivators by Gcn4p stimulates multiple steps of transcription in vivo. Mol. Cell. Biol. 25:5626-5638.
30. Granger, D. L., J. R. Perfect, and D. T. Durack. 1985. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J. Clin. Invest. 76:508-516.
31. Grant, P. A., D. E. Sterner, L. J. Duggan, J. L. Workman, and S. L. Berger. 1998. The SAGA unfolds: convergence of transcription regulators in chromatin- modifying complexes. Trends Cell Biol. 8:193-197.
32. Grunstein, M. 1990. Histone function in transcription. Annu. Rev. Cell Biol. 6:643-678.
33. Huisinga, K. L., and B. F. Pugh. 2004. A genome-wide housekeeping role for TFIID and a highly regulated stress-related role for SAGA in Saccharomyces cerevisiae. Mol. Cell 13:573-585.
34. Ikeda, K., D. J. Steger, A. Eberharter, and J. L. Workman. 1999. Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes. Mol. Cell. Biol. 19:855-863.
35. Ko, Y.-J., Y. M. Yu, G.-B. Kim, G.-W. Lee, P. J. Maeng, S. Kim, A. Floyd, J. Heitman, and Y.-S. Bahn. 2009. Remodeling of global transcription patterns of Cryptococcus neoformans genes mediated by the stress-activated HOG signaling pathways. Eukaryot. Cell 8:1197-1217.
36. Kraus, P. R., C. B. Nichols, and J. Heitman. 2005. Calcium- and calcineurinindependent roles for calmodulin in Cryptococcus neoformans morphogenesis and high-temperature growth. Eukaryot. Cell 4:1079-1087.
37. Kwon-Chung, K. J., and J. E. Bennett. 1992. Medical mycology, 2nd ed., p. 397-446. Lea and Febiger, Philadelphia, PA.
38. Laprade, L., V. L. Boyartchuk, W. F. Dietrich, and F. Winston. 2002. Spt3 plays opposite roles in filamentous growth in Saccharomyces cerevisiae and Candida albicans and is required for C. albicans virulence. Genetics 161: 509-519.
39. Luo, R. X., and D. C. Dean. 1999. Chromatin remodeling and transcriptional regulation. J. Natl. Cancer Inst. 91:1288-1294.
40. McDade, H. C., and G. M. Cox. 2001. A new dominant selectable marker for use in Cryptococcus neoformans. Med. Mycol. 39:151-154.
41. Natarajan, K., M. R. Meyer, B. M. Jackson, D. Slade, C. Roberts, A. G. Hinnebusch, and M. J. Marton. 2001. Transcriptional profiling shows that Gcn4p is a master regulator of gene expression during amino acid starvation in yeast. Mol. Cell. Biol. 21:4347-4368.
42. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Wayne, PA.
43. Nichols, C. B., Z. H. Perfect, and J. A. Alspaugh. 2007. A Ras1-Cdc24 signal transduction pathway mediates thermotolerance in the fungal pathogen Cryptococcus neoformans. Mol. Microbiol. 63:1118-1130.
44. Odom, A., M. Del Poeta, J. Perfect, and J. Heitman. 1997. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob. Agents Chemother. 41:156-161.
45. Odom, A., S. Muir, E. Lim, D. L. Toffaletti, J. Perfect, and J. Heitman. 1997. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16:2576-2589.
46. O'Meara, T. R., D. Norton, M. S. Price, C. Hay, M. F. Clements, C. B. Nichols, and J. A. Alspaugh. 2010. Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog. 6:e1000776.
47. Pascual-Ahuir, A., R. Serrano, and M. Proft. 2001. The Sko1p repressor and Gcn4p activator antagonistically modulate stress-regulated transcription in Saccharomyces cerevisiae. Mol. Cell. Biol. 21:16-25.
48. Reference deleted.
49. Perfect, J. R. 2006. Cryptococcus neoformans: the yeast that likes it hot. FEMS Yeast Res. 6:463-468.
50. Pitkin, J. W., D. G. Panaccione, and J. D. Walton. 1996. A putative cyclic peptide efflux pump encoded by the TOXA gene of the plant-pathogenic fungus Cochliobolus carbonum. Microbiology 142:1557-1565.
51. Pukkila-Worley, R., Q. D. Gerrald, P. R. Kraus, M.-J. Boily, M. J. Davis, S. S. Giles, G. M. Cox, J. Heitman, and J. A. Alspaugh. 2005. Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot. Cell 4:190-201.
52. Rachini, A., D. Pietrella, P. Lupo, A. Torosantucci, P. Chiani, C. Bromuro, C. Proietti, F. Bistoni, A. Cassone, and A. Vecchiarelli. 2007. An anti-ß- glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect. Immun. 75:5085-5094.
53. Reese, A. J., A. Yoneda, J. A. Breger, A. B. H. Liu, C. L. Griffith, I. Bose, M.-J. Kim, C. Skau, S. Yang, J. A. Sefko, M. Osumi, J.-P. Latge, E. Mylonakis, and T. L. Doering. 2007. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol. Microbiol. 63:1385-1398.
54. Retini, C., A. Vecchiarelli, C. Monari, F. Bistoni, and T. R. Kozel. 1998. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect. Immun. 66:664-669.
55. Roberts, S. M., and F. Winston. 1997. Essential functional interactions of SAGA, a Saccharomyces cerevisiae complex of Spt, Ada, and Gcn5 proteins, with the Snf/Swi and Srb/Mediator complexes. Genetics 147:451-465.
56. Sambrook J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
57. Sellam, A., C. Askew, E. Epp, H. Lavoie, M. Whiteway, and A. Nantel. 2009. Genome-wide mapping of the coactivator Ada2p yields insight into the functional roles of SAGA/ADA complex in Candida albicans. Mol. Biol. Cell 20:2389-2400.
58. Smith, M. M. 1991. Histone structure and function. Curr. Opin. Cell Biol. 3:429-437.
59. Syntichaki, P., I. Topalidou, and G. Thireos. 2000. The Gcn5 bromodomain co-ordinates nucleosome remodelling. Nature 404:414-417.
60. Toffaletti, D. L., T. H. Rude, S. A. Johnston, D. T. Durack, and J. R. Perfect. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175:1405-1411.
61. Vecchiarelli, A., C. Retini, D. Pietrella, C. Monari, C. Tascini, T. Beccari, and T. Kozel. 1995. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect. Immun. 63:2919-2923.
62. Wang, L., L. Liu, and S. L. Berger. 1998. Critical residues for histone acetylation by Gcn5, functioning in Ada and SAGA complexes, are also required for transcriptional function in vivo. Genes Dev. 12:640-653.
63. Reference deleted.
64. Wolfinger, R. D., G. Gibson, E. D. Wolfinger, L. Bennett, H. Hamadeh, P. Bushel, C. Afshari, and R. S. Paules. 2001. Assessing gene significance from cDNA microarray expression data via mixed models. J. Comput. Biol. 8:625-637.
65. Yoneda, A., and T. L. Doering. 2008. Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level. Eukaryot. Cell 7:546-549.
66. Zanton, S. J., and B. F. Pugh. 2004. Changes in genomewide occupancy of core transcriptional regulators during heat stress. Proc. Natl. Acad. Sci. U. S. A. 101:16843-16848.
67. Zaragoza, O., C. J. Chrisman, M. V. Castelli, S. Frases, M. Cuenca-Estrella, J. L. Rodríguez-Tudela, and A. Casadevall. 2008. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell. Microbiol. 10:2043-2057.
68. Zhang, W., J. R. Bone, D. G. Edmondson, B. M. Turner, and S. Y. Roth. 1998. Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO J. 17:3155-3167.
69. Zhu, X., J. Gibbons, J. Garcia-Rivera, A. Casadevall, and P. R. Williamson. 2001. Laccase of Cryptococcus neoformans is a cell wall-associated virulence factor. Infect. Immun. 69:5589-5596.